| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on March 12, 2004
Accepted on July 5, 2004
From INSERM U-545 (C.C.-P., C.F., G.L., C.L., C.C., J.-C.F., M.R.) and Institut Pasteur de Lille, Lille, France; and INSERM U-331 (L.L.), Faculté de médecine René Laënnec, Lyon, France.
* To whom correspondence should be addressed. E-mail: mustapha.rouis{at}pasteur-lille.fr.
Objective--Cholesterol accumulation in macrophages is known to alter macrophage biology. In this article we studied the impact of macrophage cholesterol loading on gene expression and identified a novel gene implicated in cell death.
Methods and Results--The regulated in development and DNA damage response 2 (REDD2) gene was strongly upregulated as THP-1 macrophages are converted to foam cells. These results were confirmed by Northern blot of RNA from human monocyte-derived macrophages (HMDM) treated with oxidized LDL (oxLDL). Human REDD2 shares 86% amino acid sequence identity with murine RTP801-like protein, which is 33% identical to RTP801, a hypoxia-inducible factor 1-responsive gene involved in apoptosis. Treatment of HMDM with desferrioxamine, a molecule that mimics the effect of hypoxia, increased expression of REDD2 in a concentration-dependent fashion. Transfection of U-937 and HMEC cells with a REDD2 expression vector increased the sensitivity of the cells for oxLDL-induced cytotoxicity, by inducing a shift from apoptosis toward necrosis. In contrast, suppression of mRNA expression using siRNA approach resulted in increased resistance to oxLDL treatment.
Conclusion--We showed that stimulation of REDD2 expression in macrophages increases oxLDL-induced cell death, suggesting that REDD2 gene might play an important role in arterial pathology.
This article has been cited by other articles:
![]() |
S. R. Kimball, A. N. D. Do, L. Kutzler, D. R. Cavener, and L. S. Jefferson Rapid Turnover of the mTOR Complex 1 (mTORC1) Repressor REDD1 and Activation of mTORC1 Signaling following Inhibition of Protein Synthesis J. Biol. Chem., February 8, 2008; 283(6): 3465 - 3475. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Brugarolas, K. Lei, R. L. Hurley, B. D. Manning, J. H. Reiling, E. Hafen, L. A. Witters, L. W. Ellisen, and W. G. Kaelin Jr. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex Genes & Dev., December 1, 2004; 18(23): 2893 - 2904. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |